United Therapeutics Corp. (NASDAQ ... a key component of its future strategy — and, CEO Martine Rothblatt contends, a solution to the worldwide organ shortage. It would also mean more space ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...